Overall, the results of this analysis of BAP1 common germline genetic variations in a large population of nearly 10,000 patients with cancer from five different cancer sites support the idea that common germline genetic variants in BAP1 playing a role in mediating the risk of developing renal cell carcinoma and lung cancer. This evidence concerns the gene BAP1 and renal cell carcinoma.